
PeLeMed is a biotechnology company focused on developing innovative small molecule drugs for oncology and viral diseases. Leveraging a precision drug design approach and an AI-driven drug discovery platform, the company aims to create novel therapies for refractory or incurable cancers and viral infectious diseases. PeLeMed has a clear mission to improve patient lives through the discovery and development of new therapeutics for unmet medical needs.

PeLeMed is a biotechnology company focused on developing innovative small molecule drugs for oncology and viral diseases. Leveraging a precision drug design approach and an AI-driven drug discovery platform, the company aims to create novel therapies for refractory or incurable cancers and viral infectious diseases. PeLeMed has a clear mission to improve patient lives through the discovery and development of new therapeutics for unmet medical needs.